Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Cash & Equivalents history
Currency unavailable · from the balance sheet
No Cash & Equivalents data reported for this period type.
Cash & Equivalents vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $420.08M USD | +149.2% | +0.7% | 47.4% | |
| Mar 2026 | $248.47M USD | +151.9% | +49.5% | 75.4% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $191.52M USD | +109.9% | +3.4% | 15.6% |
| Mar 2026 | $186.63M USD | +1204.7% | -47.5% | 98.4% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €129.59M EUR | — | — | 78.2% |
| Sep 2026 | $82.73M USD | +27.5% | +35.0% | 7.5% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $63.71M USD | -58.0% | +51.8% | 11.4% |
| Mar 2026 | $28.66M USD | -5.6% | -23.9% | 14.4% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +109.9% | +3.4% | 31.5% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.